Perioperative Support of Portosystemic Shunting Interventions in Complicated Portal Hypertension due to Liver Cirrhosis
ISSN (print) 1726-9806     ISSN (online) 1818-474X
#20171
PDF_2017-1_68-73 (Russian)

Keywords

portal hypertension
liver cirrhosis
variceal esophagogastric bleeding
TIPS procedure
adapting portal decompression

How to Cite

1.
Khoronko Y.V., Martynov D.V., Kosovtsev E.V., Lebedev Y.I. Perioperative Support of Portosystemic Shunting Interventions in Complicated Portal Hypertension due to Liver Cirrhosis. Annals of Critical Care. 2017;(1):68-73. doi:10.21320/1818-474X-2017-1-68-73

Statistic

Abstract Views: 34
PDF_2017-1_68-73 (Russian) Downloads: 53
Statistic from 01.07.2024

Language

English Русский

Social Networks

Abstract

Introduction. Portosystemic shunting interventions in the treatment of life-threatening complications of portal hypertension allow to avoid a patient’s death but they decrease the portal blood perfusion which may lead to fatal hepatic failure. The adapting portal decompression (APD) using selective vasoconstrictors preoperatively is reasonable to prevent this complication. Methods. 103 patients had undergone transjugular intrahepatic portosystemic shunt (TIPS) placement and divided on two comparable groups. 52 patients of I group who received a common standard of preoperative treatment were compared with 60 patients of II group who had pre-TIPS APD (octreotide 300 mcg subcutaneously 2 times a day during 3–5 wk) in addition of standard therapy. Postoperative complications, 6-week and 1-year mortality rate and cumulative survival were comparably evaluated. Results. Intraoperative manometry revealed a decrease of portal pressure in the group of patients who received pre-TIPS APD (II group) comparably to patients of I group (р < 0.05). As result the clinical and laboratory improvement in II group was found. 6-week mortality in I group was 1.9 % (1 patient after increasing of incidence of hepatorenal syndrome). At II group was no mortality. In 1-year period after TIPS 15 patients (28.8 %) of I group and 8 (13.3 %) of II group died. Conclusion. It’s reasonable to make the pre-TIPS APD for prevention of hepatic failure as a result of decreasing of portal blood perfusion. These findings suggest the need for selective vasoconstrictor octreotide use.

PDF_2017-1_68-73 (Russian)

References

  1. Затевахин И.И., Шиповский В.Н., Цициашвили М.Ш., Монахов Д.В. Портальная гипертензия: диагностика и лечение. Практическое руководство. М.: Буки Веди, 2015. [Zatevakhin I.I., Shipovskii V.N., Tsitsiashvili M.Sh., Monakhov D.V. Portal hypertension. Practical guidelines. Moscow: Buki Vedi, (In Russ)]
  2. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. 2007; 46: 922–938.
  3. Шерцингер А.Г., Чжао А.В., Ивашкин В.Т. и др. Лечение кровотечений из варикозно расширенных вен пищевода и желудка. Анналы хирургической гепатологии. 2013; 18(3): 110–129. [Shertsinger A.G., Chzhao A.V., Ivashkin V.T. et al. Treatment of varicose esophageal and gastric bleeding. Annaly khirurgicheskoi gepatologii. 2013; 18(3): 110–1 (In Russ)]
  4. LaBrecque D., Khan A.G., Sarin S.K. et al. Esophageal varices. World Gastroenterology Organisation Global Guidelines. Milwaukee (WI): WGO, 2014.
  5. Toomey P.G., Ross S.B., Golkar F.C. et al. Outcomes after transjugular intrahepatic portosystemic stent shunt: a bridge to nowhere. Am. J. Surg. 2013; 205(4): 441–446.
  6. Анисимов А.Ю., Верткин А.Л., Девятов А.В. и др. Практические рекомендации по лечению кровотечений из варикозно расширенных вен пищевода и желудка. Московский хирургический журнал. 2013; 6: 41–54. [Anisimov A.Yu., Vertkin A.L., Devyatov A.V. et al. Practical recommendations for treatment of variceal esophageal and gastric bleedings. Moskovskii khirurgicheskii zhurnal. 2013; 6: 41–54. (In Russ)]
  7. Клинические рекомендации по лечению кровотечений из варикозно расширенных вен пищевода и желудка. М.–Воронеж, 2014. [Clinical recommendations for treatment of variceal esophageal and gastric bleeding. Moscow–Voronezh, 2014. (In Russ)]
  8. De Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. 2010; 53(4): 762–768.
  9. Хоронько Ю.В., Дударев С.И., Глебов К.А. Адаптирующая портальная декомпрессия и повышение эффективности портосистемных шунтирующих вмешательств при осложненной портальной гипертензии. Медицинский вестник Юга России. 2016; 3: 100–104. [Khoronko Yu.V., Dudarev S.I., Glebov K.A. Adapting portal decompression for elevation of efficacy of portosystemic shunting operations in portal hypertension. Meditsinskii vestnik Yuga Rossii. 2016; 3: 100–104. (In Russ)]
  10. Шиповский В.Н. Техника операции ТИПС. Практическое руководство. М.: Издатель И.В. Балабанов, 2010. [Shipovskii V.N. Technique of TIPS operation. Practical guidance. Moscow: I.V. Balabanov Publ., 2010. (In Russ)]
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2017 ANNALS OF CRITICAL CARE